Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:

Blackberry (BBRY) : "This stock has had a very big move, but there is some substance behind it."

Exact Sciences (EXAS) : "This one could have a lot of short term risk but it it has taken the country by storm."

Splunk (SPLK) : "I think they're doing well. I'm not giving up on them."

Freeport-McMoRan (FCX) : "I think $11 to $12 is the bottom. I don't know what gives it upside though."

New Residential Investment (NRZ) : "These are companies that don't tell you what they are investing in. I don't invest in things I can't see."

Range Resources (RRC) : "It's all about the weather. If we don't have a hot summer, it's not going higher."

Nutanix (NTNX) : "Everyone likes cloud computing, but this is more expensive than Salesforce.com (CRM) ."

AstraZeneca (AZN) : "This is a cheap stock with a good yield. I do like it."

Meanwhile, over on Real Money, Cramer takes a closer look at the companies in the realm of cloud computing. Find out which ones he thinks are poised to profit with a free trial subscription to Real Money.

Cramer and the AAP team are telling their investment club members that they see the news from Arconic (ARNC) about its proxy battle as a win for shareholders. Get in on the conversation with a free trial subscription to Action Alerts PLUS.

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

To read a full recap of this episode of "Mad Money," click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had a position in ARNC.

If you liked this article you might like

Shrug Off The Apple-FANG Bite: Cramer's 'Mad Money' Recap (Thur 9/14/17)

Arconic, Idexx Laboratories, AbbVie: 'Mad Money' Lightning Round

Don't Get Shaken Out of Good Stocks: Cramer's 'Mad Money' Recap (Wed 9/13/17)